NCT01734265View on ClinicalTrials.gov

Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2013

Conditions
AllergyRhinitisRhinoconjunctivitisSeasonal Asthma
Interventions
DRUG

Depigoid 50% Grasses/50% Olea europaea (2000DPP/ml)

DRUG

Depigoid 50% Grasses/50% Parietaria judaica (2000DPP/ml)

Trial Locations (4)

41009

H. Virgen Macarena, Seville

41013

H. Virgen del Rocío, Seville

46800

H. Luis Alcañiz, Xàtiva

08243

H. Manresa, Manresa

Sponsors
All Listed Sponsors
lead

Laboratorios Leti, S.L.

INDUSTRY

NCT01734265 - Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml). | Biotech Hunter | Biotech Hunter